Topuz et al. demonstrated that plasma adropin levels are reduced in type 2 diabetes mellitus (T2DM) patients with ED, as measured by brachial flow-mediated dilatation (FMD), whereas Oruc et al. demonstrated the same for patients with established metabolic syndrome using FMD as well [40,41]. Here, ENHO is linked to type 2 diabetes mellitus.